Study suggests omega-3 in mothers' diets may lower children's risk of type 1 diabetes

May 4, 2017

New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) suggests that omega 3 polyunsaturated fatty acids (PUFAs), derived primarily from fish in maternal diet during pregnancy or lactation, may help protect infants at high risk of type 1 diabetes (T1D) from developing the disease.

If confirmed, this could mean that increasing the intake of fish-derived fatty acids and the duration of breastfeeding may have beneficial effects by reducing the autoimmune responses that lead to T1D.

More than 20 million people worldwide are affected by T1D—an autoimmune disease in which the immune system turns on the body and destroys insulin-producing beta cells in the pancreas. The subclinical disease process can be detected in asymptomatic individuals by identifying autoantibodies that develop in infancy or early childhood. Fatty acids have been shown to alter the immune system and inflammatory reactions and may play a role in the development of type 1 diabetes-related autoimmunity. However, evidence to date has been inconclusive.

In this new study, Dr Sari Niinistö at the National Institute of Health and Welfare, Helsinki, Finland and colleagues investigated whether serum fatty levels during infancy are related to the development of autoimmunity among children at increased genetic risk of developing T1D from the Finnish 'Type 1 Diabetes Prediction and Prevention Study'. In particular, they looked at whether especially high levels of omega 3 PUFAs reduce the risk of autoimmune responses that are associated with clinical disease.

Between 1997 and 2004, 7782 genetically predisposed newborns were monitored for islet cell autoantibodies, with blood samples drawn at regular intervals between 3 and 24 months of age, and then annually thereafter up to age 15, to determine islet autoimmunity. Questionnaires and food diaries were used to record breastfeeding and formula use—the main dietary sources of fatty acids in early infancy. 240 infants who developed islet autoimmunity (and 480 matched control infants) had their serum total fatty acid composition analysed from samples collected at the age of 3 and 6 months. The research team also assessed these positive cases for earlier signs of insulin and (GAD) autoantibodies—both closely related to the development of type 1 diabetes.

Results showed that high serum levels of fish-derived fatty acids (docosahexaenoic acid; DHA and docosapentaenoic acid; DPA) were associated with lower risk of early (insulin) autoimmunity. However, high serum levels of alpha-linolenic acid (ALA) and high ratios of arachidonic acid (AA):DHA and omega 6:omega 3 PUFA were linked to higher risk.

The researchers also found that fatty acid status in infants strongly reflected the type of milk feeding. Breastfed infants had higher serum levels of fatty acids (e.g., pentadecanoic, palmitic, DPA, and DHA) associated with lower risk of type 1 diabetes-related autoimmunity compared to non-breastfed infants. Quantity of breast milk consumed further reduced the risk, whereas the amount of cow's milk-based formula was associated with higher risk of developing earlier (insulin) autoimmunity.

Despite the relatively small number of cases of insulin and GAD autoimmunity, the study revealed a number of clear links between fatty acid levels in infancy and type 1 diabetes-related autoimmunity. These were not affected when the researchers took into account other potential variables such as familial diabetes, maternal education, and amount of cow's milk in diet.

The results point to new directions for tackling type 1 diabetes. But the authors caution that an association does not imply causality, and they say that more studies are needed to confirm whether fatty acids can protect children from autoimmune responses that can trigger type 1 diabetes. However, they add, "[Our] findings support the view that breastfeeding, or some components of breast milk, including , are protective, particularly with early ...[and] that long-chain omega-3 status during the early months, at a time when the immune system is maturing and being programmed, is critical."

Explore further: Omega-3 fatty acid supplementation may treat autoimmunity in type 1 diabetes

More information: Diabetologia (2017). link.springer.com/article/10.1 … 07/s00125-017-4280-9

Related Stories

Omega-3 fatty acid supplementation may treat autoimmunity in type 1 diabetes

April 4, 2017
Type I diabetes (T1D) is an autoimmune condition that develops after the immune system attacks and destroys pancreatic β cells, leading to impaired insulin production. Currently, no therapies can successfully reverse the ...

High serum omega-6 polyunsaturated fatty acid concentrations linked to lower risk of type 2 diabetes

March 24, 2016
A new study from the University of Eastern Finland shows that high serum omega-6 polyunsaturated fatty acid concentrations are linked to a significantly reduced risk of type 2 diabetes. The findings were published in the ...

Different types of PUFAs are associated with differential risks for type 2 diabetes

July 19, 2016
Different types of circulating polyunsaturated fatty acids (PUFAs) are associated with differing future risk of type 2 diabetes, according to a large European study authored by Nita Forouhi of the MRC Epidemiology Unit at ...

Fish derived serum omega-3 fatty acids help reduce the risk of type 2 diabetes

January 14, 2014
High concentrations of serum long-chain omega-3 fatty acids may help reduce the risk of type 2 diabetes, according to a University of Eastern Finland study published recently in Diabetes Care. The sources of these fatty acids ...

Study finds association between consumption of certain fatty acids and developing type 2 diabetes in women

September 13, 2016
New research presented at the European Association for the Study of Diabetes (EASD) meeting in Munich, Germany (12-16 September) shows that consumption of certain fatty acids is associated with an increased risk of developing ...

Novel lipid mediators may play role in omega-3 PUFA effects

June 25, 2016
(HealthDay)—Novel lipid mediators may be involved in the beneficial effects associated with omega-3 polyunsaturated fatty acids (PUFAs) in obesity, according to a study published online June 16 in Diabetes.

Recommended for you

Scientists reverse diabetes in a mouse model using modified blood stem cells

November 15, 2017
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) ...

Pregnancy-related conditions taken together leave moms—and dads—at risk

November 14, 2017
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team ...

Study reveals how a very low calorie diet can reverse type 2 diabetes

November 9, 2017
In a new study, a Yale-led research team uncovers how a very low calorie diet can rapidly reverse type 2 diabetes in animal models. If confirmed in people, the insight provides potential new drug targets for treating this ...

Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs

November 7, 2017
Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.

Researchers link Western diet to vascular damage and prediabetes

October 31, 2017
Could short-term exposure to the average American diet increase one's risk for developing diabetes and cardiovascular disease? According to a recent study funded by the American Heart Association (AHA), researchers from New ...

Researchers design synthetic beta cells to secrete insulin in response to high blood sugar

October 30, 2017
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.